Antagonistic human FcγRIIB (CD32B) antibodies have anti-tumor activity and overcome resistance to antibody therapy in vivo.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Andrew Davies Andrew T Vaughan Mats Jerkeman Sjef Verbeek Emily L Williams Peter Johnson Mark S Cragg |
| Publication date | April 1, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |